bucladesine has been researched along with Autoimmune Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calsolari, MR; Chaves, MM; Costa, DC; Cunha, EP; Ferreira, IC; Horta, BC; Lima e Silva, FC; Nogueira-Machado, JA; Perilo, CS | 1 |
Handberg, A; Tally, M; Wallberg-Henriksson, H; Zierath, JR | 1 |
Beshay, E; Croze, F; Prud'homme, GJ | 1 |
3 other study(ies) available for bucladesine and Autoimmune Diabetes
Article | Year |
---|---|
Modulation of the production of reactive oxygen species (ROS) by cAMP-elevating agents in granulocytes from diabetic patients: an Akt/PKB-dependent phenomenon.
Topics: Adult; Bucladesine; Cyclic AMP; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Granulocytes; Humans; Male; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Reference Values | 2006 |
C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation.
Topics: 3-O-Methylglucose; Adrenergic beta-Agonists; Adult; Biological Transport; Biopsy; Bucladesine; C-Peptide; Diabetes Mellitus, Type 1; Enzyme Activation; Glucose; Humans; In Vitro Techniques; Insulin; Isoproterenol; Kinetics; Male; Methylglucosides; Muscle, Skeletal; Receptor, Insulin; Recombinant Proteins | 1996 |
The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Autoimmune Diseases; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Diabetes Mellitus, Type 1; Dibutyryl Cyclic GMP; Disease Models, Animal; Drug Evaluation, Preclinical; Enterotoxins; Enzyme Induction; Female; Interferon-gamma; Interleukin-12; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred NOD; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Pentoxifylline; Phosphodiesterase Inhibitors; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rolipram; Tumor Necrosis Factor-alpha | 2001 |